MicroStrategy offers leveraged Bitcoin exposure, amplifying risk but potentially offering higher returns with repurchasing options.

markets, mstr, debt, convetible, notes, yield, saylor, AUM, holdings, equity, conversion, risk, shareholdersRead More

You might also be interested in reading Aclaris Therapeutics GAAP EPS of -$0.12, revenue of $1.46M.